Related Experiment Video
Updated: Jun 3, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
[HIV and AIDS: what's new in 2010?]
Alexandra Calmy1, Véronique Schiffer, Bernard Hirschel
1Unite VIH/sida, Service de maladies infectieuses, Département de medecine interne, HUG, 1211 Genève 14.
Abstract:
Antiretroviral therapy is now simpler than ever, with one tablet once daily being the gold standard for the development of new combinations. Indications for treatment initiation have now been extended before moderate immune suppression, taking in account not only the individual benefit, but also the public health aspect of preventing HIV transmission to a sexual partner. New preventing methods have been tested in 2010: microbicides as well as dual antiretroviral treatment in HIV-negative high risk population as a chemoprophylaxis have been published. If these last two tools offer some options for the future, their applicability at a large scale warrant further development.
More Related Videos
Related Concept Videos
Sexually Transmitted Infections
Retrovirus Life Cycles
Inhibitors of Virion Maturation and Assembly
Viral Hepatitis I: Introduction
Human Virome
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...

